XLRN News and Press, Acceleron Pharma Inc. From 10/23/21

NEW YORK, NY / ACCESSWIRE / October 23, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Aspen Technology, Inc. (NASDAQ:AZPN) concerning potential violations of the federal securities laws and/or breaches of fiduciary dut...

NEW YORK, NY / ACCESSWIRE / October 21, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Umpqua Holdings Corporation (NASDAQ:UMPQ) concerning potential violations of the federal securities laws and/or breaches of fiduciar...

NEW YORK, NY / ACCESSWIRE / October 15, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Columbia Banking System, Inc. (NASDAQ:COLB) concerning potential violations of the federal securities laws and/or breaches of fiduci...

Fixed income investor Bill Gross reiterates his view on the "garbage" bond market, saying 10-year U.S. Treasury yields are likely to rise to 2% over the next year, according to his October Investment Outlook. The 10-year UST yield appears to have formed resistance at around 1.60% this week, n...

An understaffed U.S. Federal Trade Commission is taking a longer and harder look at deals even as merger activity surges. 369 deals fell under review requirements in August, twice as many as the same month last year. A higher price and bigger break fees can compensate somewhat for...

NEW YORK, NY / ACCESSWIRE / October 8, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Acceleron Pharma Inc. (NASDAQ:XLRN) concerning potential violations of the federal securities laws and/or breaches of fiduciary dutie...

First, there were rumors that Merck (NYSE: MRK) might acquire Acceleron Pharma (NASDAQ: XLRN) . Then those rumors were confirmed, with the big pharma company announcing plans to buy Acceleron for $11.5 billion. In this Motley Fool Live video recorded on Sept. 29, 2021 ...

NEW YORK, NY / ACCESSWIRE / October 6, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Acceleron Pharma Inc. (NASDAQ:XLRN) concerning potential violations of the federal securities laws and/or breaches of fiduciary dutie...

With patent protection for blockbuster cancer therapy Keytruda set to expire in 2028, Merck (NYSE:MRK) is on the deal hunt, The Financial Times reports citing Mirati Therapeutics (NASDAQ:MRTX), Arcturus Therapeutics (NASDAQ:ARCT), and Biogen (NASDAQ:BIIB) as potential candidates. Ac...

Merck acquires Acceleron for $180 per share in cash. Amicus Therapeutics to launch a genetic medicine company, Caritas Therapeutics through a business combination agreement with ARYA Sciences Acquisition Corp IV. Five9 and Zoom Video Communications mutually terminate their merger ...